Literature DB >> 28274757

An evaluation of our experience in position verification of catheters used for interstitial high-dose-rate brachytherapy of solitary bladder tumors.

S J E A Bus1, N G Leus2, B J Oosterveld2, M P R Van Gellekom2, G J M van de Loop2, E M van der Steen-Banasik2.   

Abstract

PURPOSE: The goal of this study was to verify the position of catheters used over 4 days for brachytherapy of solitary bladder tumors. METHODS AND MATERIALS: The study covered three phases. Shifting of catheters was studied using daily position verification CT scans of 20 patients. The possibility to omit the CT scan on Day 2 by adding a loading margin of 4 mm on each side was studied using data of 5 patients. Whether the Day 4 verification CT scan could be omitted if this margin was used, was studied for another group of 10 patients, comparing the Day 3 treatment plan to the Day 4 CT scan.
RESULTS: An average catheter shift on Days 2, 3, and 4 of, respectively, -0.3 mm (-8 to 10 mm), -0.5 mm (-14 to 10 mm), and -0.1 mm (-16 to 28 mm) was found over the measurements at both sites of the catheter. Including only shifts causing underdosing of the clinical target volume (CTV), the average shift on Days 2, 3, and 4 was, respectively, -3.6 mm (-1 to -8 mm), -5.4 mm (-1 to -14 mm), and -5.3 mm (-1 to -16 mm). After adding a loading margin, the CTV was covered on Day 2; however, the margin was not sufficient for Days 3 and 4. On Day 4, in 2/10 patients, the CTV was not completely covered. In 5/10 patients, an increased 200% isodose volume was found.
CONCLUSIONS: Position verification is necessary in bladder brachytherapy. If a 4-mm margin on each side of the loading pattern was added, position verification on Day 2 could be omitted. The verification CT scan of Days 3 and 4 is still necessary.
Copyright © 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Brachytherapy; Catheter displacement; High-dose-rate; Position verification; Radiation therapy

Mesh:

Year:  2017        PMID: 28274757     DOI: 10.1016/j.brachy.2017.01.013

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  2 in total

1.  Don't forget the bladder!

Authors:  Bernard J Oosterveld; Elzbieta M van der Steen-Banasik; Geert A Smits
Journal:  J Contemp Brachytherapy       Date:  2018-04-30

Review 2.  Perpetual role of brachytherapy in organ-sparing treatment for bladder cancer: a historical review.

Authors:  Elzbieta Van der Steen-Banasik; Bernard Oosterveld; Geert Smits; Els Atema; Marion Van Gellekom; Marie Haverkort; Andries Visser
Journal:  J Contemp Brachytherapy       Date:  2020-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.